Spyre Therapeutics (SYRE) earnings

Earnings (net income) · fiscal 2025
-$155.20M

Spyre Therapeutics (SYRE) reported net income of -$155.20M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$208.02M. Figures as of 18 Nov 2026, 04:58 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$155.20M
Highest on record
-$10.35Mfiscal 2014
Lowest on record
-$338.79Mfiscal 2023
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Spyre Therapeutics earnings, in more detail

Across the 12 fiscal years on record (2014–2025), the highest was -$10.35M in fiscal 2014 and the lowest -$338.79M in fiscal 2023.

History · 12 fiscal years

Earnings (net income) by fiscal year

Spyre Therapeutics earnings, year by year

Spyre Therapeutics (SYRE) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$155.20M—
2024-$208.02M—
2023-$338.79M—
2022-$83.82M—
2021-$65.80M—
2020-$80.89M—
2019-$78.25M—
2018-$44.35M—
2017-$27.24M—
2016-$21.70M—
2015-$11.30M—
2014-$10.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Spyre Therapeutics and comparable companies
CompanyEarnings (net income)Fiscal year
Vaxcyte PCVX-$766.63M2025
Bio-Rad Laboratories BIO$759.90M2025
Molina Healthcare MOH$472.00M2025
Spyre Therapeutics SYRE-$155.20M2025
Qiagen QGEN$424.88M2025
Insulet PODD$247.10M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SYRE

Spyre Therapeutics, figure by figure

Spyre Therapeutics (SYRE) overview: price, valuation and scorecardAll health care companies by market value

Spyre Therapeutics earnings: questions and answers

What is Spyre Therapeutics's net income?

Spyre Therapeutics (SYRE) reported net income of -$155.20M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$208.02M.

What are the highest and lowest net income figures on record for Spyre Therapeutics?

Across the 12 fiscal years on record (2014–2025), the highest was -$10.35M in fiscal 2014 and the lowest -$338.79M in fiscal 2023.

How is Spyre Therapeutics's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Spyre Therapeutics (SYRE) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/SYRE/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.